Skip to main content
. Author manuscript; available in PMC: 2010 Oct 6.
Published in final edited form as: Clin Cancer Res. 2009 Sep 15;15(18):5646–5661. doi: 10.1158/1078-0432.CCR-09-0377

Table 3.

Key biomarkers of differences in lung cancer between ever smokers and never smokers

Biomarker Never smokers Reference
TP53 mutation spectrum Lower frequency of G:C to T:A mutations
Lower frequency of mutations
Lower frequency of mutations at hotspots
Hainaut et al. (102)
Vahakangas et al. (43)
Toyooka et al. (98)
KRAS mutations Lower frequency
Lower frequency of transversions
Kosaka et al. (36); Tam et al. (39)
Riely et al. (44)
STK11 (LBK1) mutations Lower frequency Koivunen et al. (49)
EGFR mutations Higher frequency Mitsudomi et al. (148); Shigematsu et al. (23,41)
HER2 mutations Higher frequency Shigematsu et al. (38)
EML4-ALK transloations Higher frequency Wong et al. (50)
N-tyr expression Higher level Le Calvez et al. (111)